NFKB1 and gastric cancer: It has also been shown to reduce the growth of gastric cancer cells by modulation of H19/NF-κB/FLIP signaling 14, as well as esophageal squamous cell cancer via the MAPK/ERK axis 15 and growth of B16F10 mouse melanoma cells via NF-κB 16.